SEARCH

SEARCH BY CITATION

References

  • 1
    Yoo KY, Kang D, Park SK et al . Epidemiology of breast cancer in Korea: concurrence, high-risk groups, and prevention. J Korean Med Sci 2002; 17: 16.
  • 2
    Ministry of Health and Welfare. Report of the National Cancer Control. Seoul, Korea: Ministry of Health and Welfare, 2003.
  • 3
    Korean Institute of Health and Social Affairs. The Third Korea National Health and Nutrition Examination Survey (KNHANES III), 2005 – Health Examination. Seoul, Korea: Ministry of Health and Welfare, 2006.
  • 4
    Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002; 137: 34760.
  • 5
    Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE. Screening mammography in women 40–49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 2007; 146: 51626.
  • 6
    Mandelblatt J, Saha S, Teutsch S et al . The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the US Preventive Services Task Force. Ann Intern Med 2003; 139: 83542.
  • 7
    Barratt AL, Les Irwig M, Glasziou PP, Salkeld GP, Houssami N. Benefits, harms and costs of screening mammography in women 70 years and over: a systematic review. Med J Aust 2002; 176: 26671.
  • 8
    Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin 2004; 54: 4152.
  • 9
    Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents, No. VIII. Lyon, France: International Agency for Research on Cancer, 2002.
  • 10
    Minami Y, Tsubono Y, Nishino Y, Ohuchi N, Shibuya D, Hisamichi S. The increase of female breast cancer incidence in Japan: emergence of birth cohort effect. Int J Cancer 2004; 108: 9016.
  • 11
    Ries LAG, Melbert D, Krapcho M et al . SEER Cancer Statistics Review, 1975–2004. Bethesda, USA: National Cancer Institute, 2007.
  • 12
    Office for National Statistics. Cancer Statistics Registrations: Registrations of Cancer Diagnosed in 2005. London: National Statistics, 2008.
  • 13
    Hospital Authority. Cancer Incidence and Mortality in Hong Kong. Hong Kong: Hong Kong Cancer Registry, 2004.
  • 14
    Ajiki W, Tsukuma H, Oshima A. Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol 2004; 34: 3526.
  • 15
    Lee SY, Jeong SH, Kim J, Jung SH, Song KB, Nam CM. Scheduling mammography screening for the early detection of breast cancer in Korean women. J Med Screen 2007; 14: 2059.
  • 16
    Lee SJ, Zelen M. Scheduling periodic examinations for the early detection of disease: applications to breast cancer. J Am Stat Assoc 1998; 93: 127181.
  • 17
    Drummond M, Cooke J, Walley T. Economic evaluation under managed competition: evidence from the UK. Soc Sci Med 1997; 45: 58395.
  • 18
    Ohnuki K, Kuriyama S, Shoji N, Nishino Y, Tsuji I, Ohuchi N. Cost-effectiveness analysis of screening modalities for breast cancer in Japan with special reference to women aged 40–49 years. Cancer Sci 2006; 97: 12427.
  • 19
    Carney PA, Miglioretti DL, Yankaskas BC et al . Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003; 138: 16875.
  • 20
    Office for National Health Insurance Corporation. The Contracting Report of Medical Cost in Korea. Seoul, Korea: National Health Insurance Corporation, 2007.
  • 21
    Zelen M, Feinleib M. On the theory of screening for chronic diseases. Biometrika 1969; 56: 60114.
  • 22
    Day NE, Walter SD, Tabar L. The sensitivity and lead time of breast cancer screening: a comparison of the results of different studies. In: DayNE, MillerAB, eds. Screening for Breast Cancer. Stuttgart: Hans Huber, 1984.
  • 23
    Tabar L, Vitak B, Chen HH et al . The Swedish Two-County Trial twenty years later: updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 2000; 38: 62551.
  • 24
    International Agency for Research on Cancer. IARC Handbook of Cancer Prevention: Breast Cancer Screening, vol. 7. Lyon, France: IARC, 2002.
  • 25
    US Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med 2002; 137: 3446.
  • 26
    Fletcher SW, Elmore JG. Clinical practice: mammographic screening for breast cancer. N Engl J Med 2003; 348: 167280.
  • 27
    Health Council of the Netherlands. The Benefit of Population Screening for Breast Cancer with Mammography. Hague, Netherlands: Health Council of the Netherlands, 2002.
  • 28
    Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001; 358: 13402.
  • 29
    Olsen O, Gøtzsche PC. Screening for Breast Cancer with Mammography, Update Software, Issue 3. Oxford, UK: Cochrane Library, 2003.
  • 30
    Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. J Am Med Assoc 2005; 293: 124556.
  • 31
    Choi KS, Park EC, Shin HR, Kim CM, Oh DK. National Cancer Screening Program in Korea. J Korean Assoc Cancer Prev 2004; 9: 11622.
  • 32
    Wong IO, Kuntz KM, Cowling BJ, Lam CKL, Leung GM. Cost effectiveness of mammography screening for Chinese women. Cancer 2007; 110: 88595.
  • 33
    Cuzick J, Cafferty FH, Edwards R et al . Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK Flexible Sigmoidoscopy Screening Trial. J Med Screen 2007; 14: 17885.
  • 34
    Fletcher SW, Black W, Harris R et al . Report of the international workshop on screening for breast cancer. J Natl Cancer Inst 1993; 85: 164456.